Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of duloxetine in patients with osteoarthritis of the knee
jRCT2080222625Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine in knee osteoarthritis (OA), sponsored by Shionogi & Co., Ltd.
02
Drugs
duloxetine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2080222625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222625.